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In growing tissues, cell fitness disparities can pro-
voke interactions that promote stronger cells at the
expense of the weaker in a process called cell
competition. Themechanistic definition of cell fitness
is not understood, nor is it understood how fitness
differences are recognized. Drosophila cells with
extra Myc activity acquire ‘‘supercompetitor’’ status
upon confrontation with wild-type (WT) cells, pro-
mpting the latter’s elimination via apoptosis. Here
we show that such confrontation enhances glycolytic
flux in Myc cells and promotes their fitness and pro-
liferation in a p53-dependent manner. Whereas p53
loss in noncompeting Myc cells is inconsequential,
its loss impairs metabolism, reduces viability, and
prevents the killing activity of Myc supercompetitor
cells. We propose that p53 acts as a general sensor
of competitive confrontation to enhance the fitness
of the ‘‘winner’’ population. Our findings suggest
that the initial confrontation between precancerous
and WT cells could enhance cancer cell fitness and
promote tumor progression.
INTRODUCTION
In growing epithelia, information about growth, metabolic status,
or genetic identity is shared locally among cells to establish
themselves as relatively weaker or stronger. The sensing of dif-
ferences in fitness results in competition for tissue occupancy
and improves the proliferation potential of the more robust
‘‘winner’’ cells at the expense of the relatively less robust ‘‘loser’’
cells. This conserved homeostatic process, called cell competi-
tion, facilitates the health of growing tissues and aids in tissue
size regulation (reviewed in Baker, 2011; Johnston, 2009). The470 Cell Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc.best-characterized examples of cell competition occur between
wild-type (WT) Drosophila cells and cells mutant for one of a
number of ribosomal proteins (collectively called Minute, or
M mutants), or between WT cells and cells expressing higher
or lower amounts of Drosophila Myc (hereafter called Myc), the
sole homolog of the c-Myc transcriptional regulator and onco-
protein. Indeed, primordial wing cells that differ less than 2-fold
in Myc expression compete vigorously for occupancy of the
adult wing (de la Cova et al., 2004; Johnston et al., 1999; Moreno
and Basler, 2004). Evidence indicates that intercellular signaling
mediates competitive behavior. Winner cells transmit a killing
signal to loser cells, which die by apoptosis, and loser cell partic-
ipation promotes expansion of the winner cells (de la Cova et al.,
2004; Rhiner et al., 2010; Senoo-Matsuda and Johnston, 2007).
Cell competition is thought to be an evolutionarily conserved
mechanism of ensuring optimal organ fitness, via recognition
and elimination of cells deemed dangerous to the animal (John-
ston, 2013). Recent reports suggest that a Myc-based cell
fitness surveillance system operates at early mouse embryonic
stages to optimize development (Claverı´a et al., 2013; Sancho
et al., 2013).
How cell fitness is mechanistically defined and how fitness dif-
ferences are recognized remain unclear. Studies have identified
genes expressed in loser cells (de la Cova et al., 2004; Portela
et al., 2010; Rhiner et al., 2010), but what defines winner cells
has received little attention. Broadly, cell fitness is a cell’s capac-
ity to reproduce and populate a tissue. However, cell competi-
tion relies on relative differences in cell fitness, making winner
fitness difficult to define: WT cells are winners when growing
next to M/+ cells (Morata and Ripoll, 1975) or cells mutant for
diminutive (dm), encoding Drosophila Myc (Johnston et al.,
1999; Wu and Johnston, 2010), or c-Myc (Claverı´a et al., 2013),
but are losers when next to cells with more Myc (Claverı´a
et al., 2013; de la Cova et al., 2004; Moreno and Basler, 2004;
Sancho et al., 2013), more Yki, the transducer of the Hippo tumor
suppressor pathway (Neto-Silva et al., 2010; Tyler et al., 2007;
Ziosi et al., 2010), or more Wnt/Wingless (Vincent et al., 2011)
or JAK/STAT activity (Rodrigues et al., 2012); or with less p53
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usyk et al., 2010). Cell fitness is thus under constant surveillance
in growing tissues, and mechanisms exist to recognize dispar-
ities when they arise.
In Drosophila tissues, ectopic Myc expression drives cellular
growth, but developmental constraints prevent acceleration of
cell division; thus tissue mass is promoted by increasing cell
size, not cell number (Johnston et al., 1999). In cell culture,
however, it stimulates both growth and division, leading to a
faster proliferation rate (Senoo-Matsuda and Johnston, 2007).
In mosaic wing imaginal discs or in mixed cell populations in cul-
ture, interactions between WT and Myc-expressing cells cause
Myc cells to acquire ‘‘supercompetitor’’ behavior that increases
their reproductive fitness and enables them to overtake the tis-
sue by killing off their WT neighbors. This behavior is analogous
to cancer and suggests that cancer cells and supercompetitor
cells may use similar mechanisms to surpass normal controls
on tissue growth (Baker and Li, 2008; Johnston, 2013; Moreno,
2008). Many of c-Myc’s target genes regulate glucose meta-
bolism, and its increased expression promotes aerobic glycol-
ysis, known as the Warburg effect (Dang, 1999). This metabolic
switch is common in tumor cells and may facilitate their rapid
expansion (Assaily and Benchimol, 2006; Young and Anderson,
2008), and in combination with its potent growth-promoting
properties makes Myc activity powerfully oncogenic. The dis-
covery of Myc’s supercompetitor capacity makes its role in
tumor promotion potentially even more destructive.
We undertook these studies to probe the molecular basis of
the fitness of Myc supercompetitor cells. Using a combination
of in vivo and cell culture approaches, we confirm that simple in-
creases in Myc expression reprogrammetabolism inDrosophila,
and we demonstrate that the tumor suppressor p53 is induced
adaptively to regulate mitochondrial respiration. Strikingly, in
competitive mosaics, p53 promotes considerable enhancement
of metabolic flux in Myc cells in a distinct role. Here, p53 endows
and protects supercompetitor behavior of Myc cells: in its
absence, Myc supercompetitors no longer kill WT cells, cannot
expand as a population, have increased genomic instability,
and undergo catastrophic induction of apoptosis. Myc-express-
ing cells only require the protective role of p53 when in the
presence of WT neighbor cells. We propose that p53 detects
confrontation between Myc and WT cells and mediates a
genetic program that elevates Myc cells to supercompetitor
status. Our experiments demonstrate the determinative nature
of cellular context and suggest a mechanism by which confron-
tation between emerging cancer cells and nearby WT cells may
promote mammalian tumor formation by further boosting cell
metabolism and fitness.
RESULTS
Myc Expression Stimulates Glycolysis but Impairs
Oxidative Phosphorylation
Virtually nothing is known about the basis of the fitness advan-
tage of Myc supercompetitor cells during cell competition, but
Myc proteins have well-known roles in regulation of ribosome
biogenesis and cellular metabolism. Stimulation of glucose
uptake and conversion of pyruvate to lactate instead of acetyl
Co-A for Krebs cycle utilization (Figure 1A) is a hallmark ofCecancer cells and is thought to promote increased proliferation
(Hanahan and Weinberg, 2011); thus we asked if metabolic
changes underlay Myc supercompetitive behavior. We found
that in the absence of competition, a simple increase in Myc
expression stimulates glycolysis by examining glucose meta-
bolism in monocultures of Drosophila S2 cells stably transfected
with a Cu-inducible Myc transgene (hereafter called Myc cells).
While Cu induction on its own had little effect on metabolism
(see Figure S1 available online), induction of Myc led to sig-
nificant increases in expression of genes encoding glycolytic
enzymes, including phosphoglucose isomerase (Pgi), phospho-
fructokinase (Pfk), triose phosphate isomerase (Tpi), the glucose
transporter glut1, and impl3, encoding lactate dehydrogenase
(Ldh) (Figure 1B). Glucose consumption was also increased
in Cu-induced Myc cells, but not in uninduced Myc cells (data
not shown) or control Cu-induced S2 (WT) cells (Figure 1D),
which was accompanied by an increase in intracellular lactate
(Figure 1E). Stimulation of glycolytic gene expression and flux
by Myc is thus a conserved regulatory process. We also noted
upregulation of genes encoding proteins functioning in mito-
chondria to promote oxidative respiration in Myc-expressing
cells, including synthesis of cytochrome C oxidase (Scox),
required for assembly of cytochrome c oxidase (COX, complex
IV) (Yang et al., 2010), succinate dehydrogenase (Sdh), a com-
ponent of the electron transport chain (ETC; complex II), and
pyruvate dehydrogenase (Pdh), which catalyzes decarboxylation
of pyruvate and generates acetyl CoA for the Krebs cycle
(Figure 1C). Despite increased expression of these genes,
steady-state ATP in Myc cells was 30% lower than in WT cells
(Figure 1F). Myc expression thus reconfigures cellular meta-
bolism so that oxidative phosphorylation is displaced as the
predominant source of energy production by increased glycol-
ysis and lactic acid fermentation, resembling the Warburg effect
observed in cancer cells (Dang, 2010).
The decrease in ATP in Myc-expressing cells suggested a
defect in oxidative phosphorylation. We explored this possibil-
ity first using a mitochondrial-localized GFP (MitoGFP) to
examine mitochondria in WT and Myc-expressing cells in vivo,
in wing discs and in larval fat bodies. Fat body cells are
large and flat, facilitating mitochondrial visualization. Both WT
wing disc and fat body cells have long, filamentous, perinuclear
networks of mitochondria (Figure 1Ha, Figure S2Aa). Expres-
sion of Myc in either cell type increased mitochondrial number
compared to WT cells, consistent with Myc’s regulation of
mitochondrial biogenesis (Figure 1Hb, Figure S2Ab) (Li et al.,
2005). This was confirmed by an increase in citrate synthase
(CS) activity, a measure of mitochondrial mass, in Myc cells
in culture (Figure 1I). Compared to WT cells, Myc-expressing
wing disc or fat body cells had few filamentous mitochondria
but many small donut shapes and globules (Figure 1Hb, Fig-
ure S2Ab). Mitochondrial morphology is controlled by meta-
bolism (Rossignol et al., 2004; Youle and van der Bliek,
2012); thus this remodeling is likely due to altered metabolism
in Myc cells.
To evaluate mitochondrial respiration in WT and Myc cells,
we quantified ETC function by measuring the activities of ETC
complexes. Complex activities were normalized to CS activity
to account for mitochondrial number. The activities of com-
plexes I + III (NADH cytochrome c reductase) were similar,ll Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc. 471
Figure 1. Myc Induces Glycolysis and Reduces Oxidative Phosphorylation
(A) Schematic of glycolysis. Enzymes catalyzing reactions in glucose breakdown are bolded; those induced byMyc expression are red. See text for abbreviations.
(B) Quantitative (q) RT-PCR of glycolytic gene expression in Myc cells from monocultures. mRNA expression is normalized to actin5CmRNA and shown as fold
increase in Myc cells relative to WT cells. Significance is compared to expression in WT cells. All error bars in this figure are SD.
(C) qRT-PCR of genes required for mitochondrial respiration, as described in (B).
(D) Glucose consumption in WT or Myc cell monocultures.
(E) Intracellular lactate and pyruvate in monocultures of WT or Myc cells.
(F) Steady-state ATP in WT or Myc cell monocultures.
(G) ETC complex activity, normalized to CS activity, in Myc cells expressed as a ratio over activity in WT cells.
(H) MitoGFP labeling of mitochondria in larval fat body cells showsmitochondrial morphology. (Ha) WT cells. Area within each yellow square is magnified in single
channel images below. (Hb) Myc-expressing cells. Mitochondrial number and morphology are altered, with more donut shapes (arrow).
(I) Citrate synthase (CS) activity, an index of mitochondrial mass, as a function of total cellular protein in WT and Myc cells from monocultures.
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higher in Myc cells compared to WT (Figure 1G). The increase
in complex II activity is consistent with higher sdhmRNA expres-
sion in Myc cells. However, complex IV (cytochrome c oxidase,
COX) activity was significantly decreased in Myc cells (Fig-
ure 1G). Confirming these data, histochemical assays of Sdh
(complex II) and COX indicated that Sdh activity was equivalent
in both WT cells and Myc cells, but COX activity was reduced
specifically in the Myc cells (Figure S1E; data not shown).472 Cell Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc.p53 Buffers Myc-Dependent Glycolytic Flux and
Promotes Oxidative Respiration
Scox is the soleDrosophila homolog of themammalian synthesis
of Cytochrome cOxidase 2 (SCO2) (Porcelli et al., 2010), which is
regulated by p53, a critical sensor of cellular stresses including
DNA damage and oncogene deregulation (Sutcliffe and Brehm,
2004). p53 promotes mitochondrial respiration by positively
regulating Sco2 and inhibiting glycolysis (Matoba et al., 2006;
Vousden and Ryan, 2009). Because scox expression was
Figure 2. Homeostatic Metabolic Regulation by Drosophila p53
(A) Expression of p53 mRNA is low in WT wing discs expressing the PtcGal4 driver.
(B) Myc expression under control of PtcGal4 induces p53 mRNA (arrow points to the PtcGal4 domain).
(C) p53 activity reported by expression from the p53 activity reporter rpr-150-lacZ (red) is induced inMyc-expressing wing disc clones (green). (C0) Single channel,
b-galactosidase.
(D) qRT-PCR expression of scox, glut1, glut3, and ldh/impl3mRNA in WT S2 cells treated with treated with p53 dsRNA, expressed as a ratio to cells treated with
control dsRNA. Expression of each mRNA is normalized to actin5C mRNA. All error bars in this figure are SD.
(E) Steady-state ATP in WT or Myc cells from monocultures, treated with control or p53 dsRNA.
(F) MitoGFP in p53 mutant fat body cells. (Fa) Mitochondria have mixed morphologies. (Fb) p53 mutant cell expressing Myc.
(G) Mitochondrial mass (CS activity) is not altered by loss of p53 in Myc cells.
(H) ETC complex activity (normalized to CS activity) in Myc cells relative to WT cells, both treated with p53 dsRNA.
(I) Glucose consumption in WT and Myc cell monocultures after p53 knockdown.
(J) Intracellular lactate and pyruvate in monocultures of Myc cells or WT cells treated with p53 dsRNA.
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p53 in metabolic homeostasis. The D. melanogaster genome
contains one p53 homolog (Marcel et al., 2011) that is transcrip-
tionally upregulated in response to tissue and DNA damage
(Brodsky et al., 2004; Wells and Johnston, 2012; Wells et al.,
2006). p53 expression is low in WT wing discs (Wells and John-
ston, 2012) but was induced in cells expressing Myc (Figures 2A
and 2B) (Hulf et al., 2005; Montero et al., 2008), as was a p53Ceactivity reporter (Figure 2C) (Brodsky et al., 2000). In cell
culture, p53 mRNA was induced 2.5-fold by Myc expression
(Figure S1D).
To determine if Drosophila p53 functioned homeostatically
to counteract the Myc-induced increase in glycolytic flux, we
treated WT or Myc cells with p53 dsRNA. Indeed, this signifi-
cantly reduced scox expression and steady-state ATP relative
to controls (Figures 2D and 2E; data not shown). ETC activityll Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc. 473
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phosphorylation (ox-phos) (Figure 2H). Using MitoGFP in vivo,
we saw disrupted mitochondrial morphology in p53 mutant
wing disc cells or fat body cells with a variety of shapes including
globules and donut shapes as well as the long filaments
that predominated in WT cells (Figure 2Fa, Figure S2Ac). The
increase in mitochondrial number induced by Myc remained in
p53 mutants (Figure 2Fb, Figure S2Ad). Consistent with this,
CS activity in Myc cells treated with p53 dsRNA in culture was
similar to controls (Figure 2G). Thus, despite morphological
changes, mitochondrial mass remained the same. In contrast,
p53 dsRNA stimulated expression of glut1, glut3, and ldh
mRNAs and increased glucose consumption (Figures 2D and
2I) and intracellular lactate (Figure 2J) in WT cells and in Myc
cells. Thus although virtually undetectable in steady-state
conditions (Figure 2A), p53 is a physiological regulator of meta-
bolic homeostasis in Drosophila and restrains glycolysis while
promoting ox-phos. Moreover, our results suggest that the
increase in sdh and scox mRNAs and CS activity in Myc cells
compensates for a COX deficiency and reduced ATP.
Cell Competition EnhancesMyc-InducedMetabolic Flux
What is the effect of Myc-induced metabolic reprogramming
on cell competition? In cell-based assays, mixed populations
of WT and Myc cells foster competitive interactions mediated
by diffusible factors (Senoo-Matsuda and Johnston, 2007),
causing death of WT loser cells but proliferation of Myc winner
cells (Figures S3B and S3C). Conditioned medium (CM) gener-
ated from such cocultures contains these activities and induces
winner or loser behavior in naive cells (Figures S3A–S3C)
(Senoo-Matsuda and Johnston, 2007). We induced competition
between Myc and WT cells in coculture assays and found that
it further boosted glycolytic flux in Myc cells. In competitive
cocultures Myc cells had more lactate and less pyruvate than
Myc cells in monoculture (Figure 3G versus Figure 1E), and in
the Myc cells glucose consumption doubled (Figure 3F versus
Figure 1D). Competition also enhanced glycolytic gene expres-
sion in Myc cells. Naive WT or naive Myc cells treated with CM
from competitive cocultures (cCM) enhanced the increase in
glut1 and glut3 mRNA expression in Myc cells (Figure 3A).
hexokinase C (HK-C) and tpi mRNA were also enhanced by
competition (Figure 3A), but impl3/ldh mRNA was not. In vivo,
uptake of the fluorescent glucose derivative, 2-NBDG (2-[N-
(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose),
wasmodest in control wing disc cells (Figure 3B) but prominently
elevated in competing clones of Myc-expressing cells (Fig-
ure 3C), indicating glucose metabolism was also increased
during competition in wing discs.
Expression of pdh, sdh, and scox mRNA was enhanced by
cCM in naive Myc cells (Figure 3A) as well, but steady-state
ATP was not improved. Rather, competition further reduced
ATP to only 44% of controls (Figure 3H, Ctl). Competition-
induced enhanced glycolysis and reduced ATP were specific
to Myc cells, as lactate and ATP in WT loser cells remained
identical to WT cell in noncompetitive monocultures (Figures
3G and 3H, compare to Figure 1E). Competition mildly altered
ETC activity in Myc cells, and COX activity was further reduced
compared to monoculture controls (Figure 3I). Thus, confronta-
tion between Myc and WT cells converts Myc cells into super-474 Cell Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc.competitors and intensifies their already altered metabolism.
The significant reduction in steady-state ATP in Myc supercom-
petitors suggests glycolysis predominates over ox-phos as an
energy source.
Enhanced Metabolic Flux in Myc Supercompetitors
Requires p53
To determine if p53 functions in Myc supercompetition, we
examined cells treated with p53 dsRNA. In competitive cocul-
tures, p53 dsRNA reduced scox mRNA and steady-state ATP
even further in Myc cells (Figures 3E and 3H). Unexpectedly,
glycolytic flux was reduced by p53 dsRNA in Myc supercompe-
titors, rather than stimulated (Figures 3E–3G). Competition-
induced enhancement of glucose consumption and of glut1
and glut3 expression was abolished by p53 dsRNA (Figures 3E
and 3F). Enhanced expression of scox also required p53, indi-
cating that its increase could be triggered in response to reduced
ATP. Interestingly, expression of these genes remained higher
than in WT cells (Figure 1B); thus glycolytic changes induced
by a simple increase in Myc expression are p53 independent.
p53 dsRNA did not alter impl3/ldh expression but reduced
lactate in Myc cells, and did not affect Myc expression itself
(Figure 3G). In contrast to Myc supercompetitor cells, WT cells
from the same cocultures increased glucose consumption (Fig-
ure 3F) and lactate production (Figure 3G) in response to p53
dsRNA, as expected (Figures 2I and 2J). In p53 mutant wing
discs, Myc-induced 2-NBDG uptake remained high in the
absence of competition (i.e., EnGal4>Myc; data not shown) but
was noticeably diminished in clones of Myc supercompetitor
cells (Figure 3D). Thus, p53 is required to enhance theMyc-stim-
ulated increase inmetabolic flux. This role is specific toMyc cells
in a competitive context and distinct from p53’s normal homeo-
static function in metabolic regulation.
Enhanced Metabolism Supports Rapid Expansion
of Myc Supercompetitor Cells
Since CM from competing cocultures contains a diffusible activ-
ity that accelerates proliferation of naive Myc cells relative to
controls (Figure 4A, Figures S3B and S3C) (Senoo-Matsuda
and Johnston, 2007), we tested if it required p53-dependent
enhanced metabolic reprogramming. We used CM generated
from p53-depleted competitive cocultures to treat naive assay
cells also pretreated with p53 dsRNA. Indeed, cCM from p53-
depleted cocultures was unable to accelerate proliferation of
naive Myc cells, whereas ncCM from p53-depleted control
cocultures did not alter proliferation of these cells (Figure 4A).
The lack of proliferation-stimulating activity in cCM from p53-
depleted cocultures could be due to loss of p53’s metabolic
functions, or to another role of p53. To distinguish between
these possibilities we directly disrupted metabolism by treating
competitive co-cultures and naive assay cells with dsRNA
against glut1, cytochrome-c-d (cyt-c-d), or debcl/drob-1, a
Bcl-2 family protein involved in mitochondrial respiration (Se-
noo-Matsuda et al., 2005). Like p53 dsRNA (Figures 2E and
3H), cyt-c-d or debcl dsRNA leads to reduced cellular ATP
(N.S.-M., unpublished data) (Senoo-Matsuda et al., 2005). cCM
generated from these cocultures did not stimulate proliferation
of the naive Myc assay cells (Figure 4C, Figures S3F and S3G).
Knockdown of these genes does not compromise growth of
Figure 3. Myc-Induced Glycolysis Is Enhanced in Cell Competition and Requires p53
(A) qRT-PCR of glycolytic gene expression (normalized to actin5C mRNA) in Myc cells grown under competitive conditions (C), expressed as fold increase
over Myc cells in noncompetitive conditions (NC). White dashed line indicates base level (1). Asterisks show significance relative to Myc cells in a NC context.
All error bars in this figure are SD.
(B–D) Glucose uptake in larval wing discs.
(B) Control, RFP-expressing clones (red) with 2-NBDG uptake (green). (B0) Single channel of 2NBDG.
(C) Uptake of 2-NBDG is increased in competing Myc, RFP-expressing cells. (C0) Single channel, 2-NBDG.
(D) Glucose uptake in p53 mutant wing disc containing Myc and RFP-expressing clones. (D0) Single channel of 2-NBDG.
(E) qRT-PCR of Myc cells from competitive cocultures treated with control or p53 dsRNA. Expression of each mRNA is normalized to actin5CmRNA expression
and shows fold enhancement in Myc cells in C over NC conditions.
(F) Glucose consumption in WT and Myc cells from competitive indirect cocultures treated with p53 or control dsRNA.
(G) Intracellular lactate and pyruvate in WT and Myc cells from competitive indirect cocultures treated with control or p53 dsRNA.
(H) Steady-state ATP in WT and Myc cells from C indirect cocultures treated with control or p53 dsRNA.
(I) ETC complex activity (normalized to CS activity) in Myc cells from monocultures compared to that of naive Myc cells treated with cCM.
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depleted cocultures had little effect (Figures S3D and S3E).
Thus, treatments that disrupt metabolism in Myc supercompeti-
tor cells suppress the proliferation-stimulating activity in cCM.
As the activity is only present in cCM, and since Myc cells, but
not WT cells, respond to it, these results suggest that p53-
mediated enhanced metabolism promotes accelerated pro-
liferation of Myc supercompetitor cells in culture.
A second activity in cCM causes naive WT cells to proliferate
slower in response to cCM due to increased apoptosis (Fig-Ceure 4B) (Senoo-Matsuda and Johnston, 2007). However, cCM
from p53-depleted cocultures stimulated faster proliferation of
naive WT cells (Figure 4B). This correlated with increased
glut1, glut3, and scox expression and higher glucose consump-
tion, as expected after p53-depletion (Figure 3F; data not
shown). Thus, whereas p53 loss dampens glycolysis in Myc
supercompetitor cells, it stimulates it in WT loser cells, indicating
that p53 function in Myc cells in a competitive context is
qualitatively different from its homeostatic role in regulation
of metabolism. cCM from glut1, cyt-c-d, or debcl-depletedll Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc. 475
Figure 4. Enhanced Glycolysis Boosts Pro-
liferation of Myc Supercompetitors
(A) cCM, but not ncCM, generated from cocultures
depleted of p53 (but not control dsRNA) prevents
accelerated proliferation of naive Myc cells. Values
in (A) and (B) are the mean of five independent
experiments; cells in cocultures and naive cells
were treated with p53 or control dsRNA in this
figure. Error bars in this figure are SD.
(B) Naive WT cells treated with cCM from p53-
deficient cocultures proliferate faster than cells
treated with cCM from cocultures with control
dsRNA, and faster than ncCM-treated cells.
(C) Growth curve of Myc cells grown in cCM
and ncCM from cyt-c-d or glut1-depleted co-
cultures. Values are mean of 2 independent
experiments.
(D) Growth curve of WT cells grown in cCM
and ncCM from cyt-c-d or glut1-depleted co-
cultures. Values are mean of two independent
experiments.
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proliferation of naive WT cells (Figure 4D, Figure S3G), due to
a similar frequency of apoptosis (data not shown). The super-
competitor killing activity is thus lost in p53-deficient cCM, but
is retained in cCM from metabolically disabled cocultures.
Thus p53-mediated enhanced metabolism in Myc cells pro-
motes supercompetitor status but cannot explain every aspect
of the behavior.
During rapid growth, glutamine pools can be limiting for
macromolecular biosynthesis, and its uptake is increased in
some cancer cells (DeBerardinis et al., 2007; Yuneva et al.,
2012). We found increased expression of the glutamine syn-
thases GS1 and GS2 and an uncharacterized gene encoding
a glutaminase (CG42708) in Myc cells compared to WT cells
that was enhanced in Myc supercompetitors (Figure S4A). To
determine if glutamine uptake was altered in Myc super-
competitors, we compared glutamine consumption in non-
competitive versus competitive conditions in WT and Myc
cells. Unexpectedly, monocultures of Myc cells consumed
less glutamine than WT cells (Figure S4A). Glutamine consump-
tion slightly increased in naive Myc cells grown in cCM but
remained less than naive WT cells in cCM (Figure S4A). Thus,
glutamine utilization may play a role in Myc cells, but its uptake
is not rate limiting for rapid expansion of Myc supercompetitor
cells.
Expansion of Myc Cell Populations Requires p53
Only during Competition
Our experiments indicate that without p53, WT ‘‘loser’’ cells
became ‘‘winners’’ and proliferated more, seemingly reversing476 Cell Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc.the outcome of competition. To deter-
mine if p53 loss in vivo had the same
effect, we induced clones of loser cells
in p53 mutant wing discs using a compe-
tition assay in which all cells express
Myc constitutively at a moderate level
via a tub > myc > Gal4 gene cassette(‘‘>’’ denotes FRT site) (de la Cova et al., 2004;Wu and Johnston,
2010). ‘‘Flp-out’’ of the > myc > cassette generates cell clones
expressing UAS-GFP (loser GFP clones); these cells are WT
with respect to Myc but are disadvantaged because they are
surrounded by tub > myc > Gal4 cells (de la Cova et al., 2004).
WT loser GFP clones grew significantly slower than control
GFP clones (Figures 5A and 5C). However, in either of two p53
null mutants, loser GFP clones grew to much larger sizes (Fig-
ures 5B and 5C; data not shown), growing as well as control
clones not subject to competition (Figure 5C).
Consistent with our cell culture experiments, Myc-expressing
cell clones generated in p53 mutant wing discs grew slower
than controls (Figure S6C). Control GFP clones generated in
either WT or p53 mutant backgrounds grew at similar rates
(Figure S6C); thus loss of p53 selectively prevents expansion
of competing Myc clones. Thus, in the absence of p53, Myc
supercompetitor cells are unable to expand, while loser cells
resist competition and survive.
Expansion of the Myc population requires increased ribosome
biogenesis and activity, a signature of Myc activity manifested in
wing discs by increased cell and nucleolar size, and correlates
with increased expression of the nucleolar protein, Fibrillarin
(Fib) (Grewal et al., 2005; Johnston et al., 1999). We used these
criteria to test if p53 was required for Myc to regulate ribosomal
activity. Fib expression, nucleolar size, and cell size in Myc-
expressing clones were unaffected in p53 null mutants (Figures
S4B–S4D). We conclude that although it is required for Myc’s
supercompetitor metabolism and for expansion of the Myc
supercompetitor population, p53 is not required for Myc to
stimulate cellular growth.
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Competition
Since confrontation between WT and Myc cells endows Myc
cells with p53-dependent competitive behavior, we asked if
winner cells in other competitive contexts required p53. In the
classical paradigm of cell competition, clones of WT cells gener-
ated in aMinute (M) heterozygous background compete against
the weaker M/+ cells and proliferate to occupy large portions of
the wing disc (Morata and Ripoll, 1975; Simpson, 1979). In M(3)
RpS3/+mosaics, clones ofWT cells compete to occupy thewing
disc and, when examined after short defined time periods, grew
significantly faster than WT clones in WT discs (Figure S5A);
these findings differ from a previous report (Martı´n et al., 2009).
To test whether p53 mutant cells also ‘‘win’’ in competition
with M(3)RpS3/+ cells, we generated p53 mutant clones in
M(3)RpS3/+ wing discs. The clones grew faster than control
p53 clones in p53 mutant wing discs and still populated a large
fraction of themature wing disc. However, the rate of p53mutant
‘‘winner’’ cell proliferation was 25%slower thanWT counterparts
over the same time period (Figure S5A). We conclude that
although p53 loss does not abolish competition with M(3)
RpS3/+ cells, it compromises the accelerated proliferation of
winner cells.
In a second test, we examined competition between WT cells
and dm mutant cells. As shown previously (Neto-Silva et al.,
2010; Wu and Johnston, 2010), WT cells near dm mutant cells
gained winner status and proliferated at a faster rate than
when in a milieu of other WT cells (Figure S5B, left). In either a
hypomorphic dmP0 mutant or a null mutant dm4 background,
this was prevented by p53 loss (Figure S5B, right). Still, a p53
mutant background did not completely abolish competition, as
dm mutant clones remained small. However, in three indepen-
dent competitive contexts—Myc supercompetitor versus WT
cells, WT cells versusM/+ cells, and WT cells versus dmmutant
cells—p53 is an important mediator of the rate at which the
winner cell population expands, and therefore of the cell popula-
tion’s fitness.
p53 Is Selectively Required in Myc Supercompetitors
for Genome Stability, Survival, and Competitiveness
WT loser cells are eliminated from wing discs due to induction
of the proapoptotic factor Hid (de la Cova et al., 2004). The
number of loser cells expressing the active-caspase 3 (C3)
apoptotic marker increases soon after induction of competition
in tub > myc > Gal4 discs in either WT or p53 mutant back-
grounds (Figures 5D–5F, GFP[+]; Figures S6A and S6B). How-
ever, within 24 hr after induction in p53 mutant wing discs, we
observed three times more C3-positive Myc supercompetitor
cells than were present in a WT background (Figures 5D–5F,
GFP[]). Many C3 (+) p53 mutant, Myc supercompetitor cells
were close to GFP loser clones (Figures 5E and 5G). In addition,
many p53 mutant Myc supercompetitor cells expressed the
DNA damage marker, g-H2AX, whereas in GFP loser cells
g-H2AX was rare (Figures 5Gi–5Giii). These findings and the
fact that few competing Myc cells die in WT wing discs pro-
mpted a series of additional controls to rule out trivial causes
of cell death. When all cells in p53mutant wing discs expressed
extra Myc via an intact tub > myc > Gal4 cassette (a noncom-
petitive environment), cell death was comparable to that inCeWT controls (data not shown). The heat shock treatment used
to induce clones also did not increase C3- or g-H2AX-positive
tub > myc > Gal4 cells (Figure 5H). Notably, C3 and g-H2AX
marks did not always correlate, suggesting g-H2AX was not
due to caspase activation (Rogakou et al., 2000). Finally, neutral
GFP clones generated in p53 mutant discs did not die more
frequently than in WT discs (Figures S6C and S6D); similar
results were obtained in the S2 cell competition assay (Fig-
ure S6E). Thus, although p53 mutant, tub > myc > Gal4 cells
survive and proliferate normally in wing discs for several days
prior to stimulation of competition, within 24 hr of induction of
GFP loser clones, genome destabilization in Myc cells leads
to the appearance of g-H2AX and to increased apoptosis.
Accordingly, p53 selectively promotes the viability and genomic
integrity of Myc supercompetitors.
Without p53, the death of Myc winner cells prevents their
expansion as a population, and the WT losers gain the advan-
tage. This altered outcome could be due to a requirement for
p53 in either population. To determine which cells autonomously
require p53 function, we created p53 null FRT chromosomes
wherein the mutation was either linked or unlinked to the Gal4
inhibitor, Gal80. This allowed us to separately assess the contri-
bution of p53 to Gal4-regulated Myc cell clones and to their WT
sibling cell clones, both produced by one mitotic recombination
event (Figure 6) (de la Cova et al., 2004; Lee and Luo, 2001).
Consistent with our previous findings, Myc clones grew faster
than GFP controls at the expense of their WT sibling clones (Fig-
ures 6B and 6E). p53 loss specifically in loser clones (siblings of
Myc supercompetitor clones) did not alter their own growth or
that of the Myc clones (Figures 6A–6C). However, Myc clone
size was reduced 40% by loss of p53 (Figure 6D), to smaller
than WT control clones (Figures 6E and 6F). p53 mutant Myc
clones were also no longer competitive, allowing WT sibling
clones to grow as well as their counterparts in controls (Figures
6E–6G). p53 is thus specifically and cell-autonomously required
in Myc supercompetitor cells.
The ability of loser cells to survive whenMyc supercompetitors
lack p53 suggested the latter had lost their killing activity.
Whether this activity required cell survival—for example, for
efficient signal transmission to loser cells—remained unclear.
If survival and competitiveness are coupled, blocking death of
p53 mutant Myc supercompetitors might allow them to be
competitive. We therefore protected p53 mutant Myc cells
from death with the caspase inhibitor, P35 (Hay et al., 1994),
and measured the size of these clones and their WT sibling
clones after a defined period of growth. Expression of P35
in either WT or p53 mutant cell clones did not affect clonal
growth in controls (Figures 6H and 6J), and coexpression of
Myc and P35 did not block supercompetitor status, since their
sibling clones were smaller than controls (Figure 6J). Preventing
apoptosis allowed p53 mutant, Myc-expressing clones to grow
to the same size, and at the same rate, as WTMyc supercompe-
titor clones (Figure 6K versus Figure 6J). Thus, the inability of the
p53mutant Myc supercompetitor population to expand is due to
cell death that requires the presence of nearbyWT cells. Despite
rescue of Myc clone size, WT sibling clones were equal in size to
sibling clones in noncompetitive controls (Figure 6K); thus,
without p53, Myc cells do not transmit a killing signal to their
WT neighbors. Collectively, our results demonstrate that Mycll Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc. 477
Figure 5. Myc Supercompetitor Cells Require p53 for Genome Stability and Viability
(A) GFP+ loser clones (green) in a WT tub > myc > Gal4 wing disc. All GFP() cells express the tub > myc > Gal4 transgene. DNA is stained with Hoechst (blue).
Active caspase 3 (C3, red) marks dying cells.
(legend continued on next page)
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Myc Supercompetition Requires p53supercompetitor cells require p53 cell-autonomously for survival
and supercompetitor status.
DISCUSSION
We have addressed the basis of cell fitness during Myc-induced
supercompetition, a paradigm of cell competition with parallels
to mammalian tumor promotion. Here we extend these parallels
with our finding that in Drosophila cells, extra Myc activity
biases cells to glycolysis and lactic acid fermentation for
energy production, as c-Myc does in many cancers (Dang,
1999; Shim et al., 1997). Although they were primarily analyzed
in S2 cells, we also observed metabolic changes during com-
petition in wing discs that suggest metabolism is similarly
altered in vivo during competition. Intriguingly, our work reveals
that increasedMyc alters mitochondrial morphology and impairs
complex IV (COX) activity, thereby weakening the ETC, which
presumably causes the reduced cellular ATP in Myc cells.
Together, the compromised ETC and rise in glycolysis in Myc
cells echoes Warburg’s observation of flawed mitochondria
and increased fermentation in cancers (Warburg, 1956).
Increased glycolysis can benefit cells by freeing them from reli-
ance on the slow but efficient energy production by ox-phos
(Pfeiffer et al., 2001; Ristow and Shulz, 2009). Our finding raises
the question of whether the glycolytic increase in Myc cells is
independent of a faulty ETC, or is induced to compensate for
defective complex IV activity and low ATP.
Our results also establish evolutionary conservation of p53’s
homeostatic role in metabolic regulation in proliferating
Drosophila cells (Cheung and Vousden, 2010; Matoba et al.,
2006). Moreover, p53 balances internal metabolic changes in
Myc cells by promoting ox-phos and curbing glycolysis. That
the COX deficiency and low steady-state ATP are accompanied
by a p53-dependent increase in scox mRNA suggests p53 is
induced in Myc cells in a homeostatic response to protect
fitness. As p53 is a sensor of numerous cellular stresses, we
postulate that its activity increases in Myc cells to balance their
metabolism (Figure 7A). The relationship between Myc and p53
could feasibly function as a conserved module for adaptation
of cells to metabolic perturbation.
In striking contrast to Myc cells on their own, when Myc cells
coexist with WT cells in mixed populations they undergo several
additional p53-dependent changes: they produce (and also
resist) a diffusible killing factor, they gain an increase in repro-
ductive potential, and glycolytic flux is considerably enhanced.
Notably, these events happen within hours (de la Cova et al.,
2004; Senoo-Matsuda and Johnston, 2007). The diverse p53-(B) GFP+ loser clones (green) in a p53 mutant tub > myc > Gal4 wing disc. Dying
(C) In WT discs, loser GFP+ clones grow poorly (black line) compared to control
clones (green line) grow as well as control clones generated in parallel. Error bar
(D) In WT discs, most C3 staining is in loser GFP+ cells. Clones in (D) and (E) we
(E) C3 staining in p53mutant, tub > myc > Gal4 winner cells competing with GFP
(F) Quantification of data from (D) and (E). Mean number C3+ cells per GFP+ clone
p53 mutant backgrounds; or C3+ cells in GFP tissue/wing disc.
(G) GFP+ loser clones (green) in a p53 mutant wing disc. g-H2AX (blue in G, sep
channel in G00). Yellow boxes in each panel are magnified below (i, ii, iii); H2AX is
(H) p53mutant tub >myc > Gal4 cells do not die in the absence of cell competition
were generated. Separate channels are shown in H0, H00. Yellow triangle points to
trachea.
Cedependent changes in Myc cells imply that p53, already active
to balance metabolism, detects confrontation with WT cells via
a distinct role, initiating a new program that converts Myc cells
into supercompetitors. Enhanced glycolytic flux is clearly part
of this program, but given that p53 normally suppresses glycol-
ysis, we speculate that it is only indirectly regulated by p53.
Even so, without p53, Myc supercompetitors completely lose
the traits distinguishing them from Myc cells in a homotypic
environment, suggesting that p53 is a sensor of confrontation
between the two populations; in its absence the cells do not
‘‘recognize’’ their differences.
Supercompetitor status (and winner status in general) is an
acquired property of cells, dictated by their local environment.
Activation of Jun N-terminal kinase signaling in competing cell
populations indicates that the confrontation is stressful (de la
Cova et al., 2004; Moreno and Basler, 2004), which could elicit
additional p53 functions. If so, the degree of p53 activation
may be a proxy for the level of stress the cells receive. Thus,
Myc cells lacking p53 are viable in a homotypic setting despite
acute metabolic changes, but the additional stress of a hetero-
typic milieu leads to inviability. p53 function in Myc cells is
context dependent: it is first activated to balance metabolic
distress induced by Myc, and second, confrontation with WT
cells activates a different function of p53 that leads to a program
providing the supercompetitor phenotype. Given the rapid in-
duction of supercompetitor behavior, we speculate that post-
translational mechanisms are involved.
How is confrontation sensed by p53? With the exception of
the killing activity, the supercompetitor phenotype is an exag-
geration of existing properties of Myc cells. That heterotypic
confrontation causes a significant rise in metabolic flux in Myc
cells raises the possibility that metabolites play a role. Like
p53 depletion, direct metabolic disruption limits the fitness
increase of Myc supercompetitors, revealing an important
metabolic underpinning to their status. However, direct meta-
bolic disruption did not block production of the killing activity,
and thus metabolism cannot account for all supercompetitor
traits. Although metabolic functions of p53 are required for
some supercompetitor behaviors, our results suggest that
p53’s role in promoting fitness of WT winner cells in other
competitive contexts is related to the confrontational response,
rather than direct metabolic regulation. Still, the evidence that
p53 promotes reproductive fitness of ‘‘winner’’ cells in other
heterotypic contexts raises the possibility that p53 generally
functions as a sensor of genetic heterogeneity. Whether meta-
bolic alterations are sensed or mediate winner behavior in these
contexts remains to be seen.cells (marked with C3) are mostly GFP-negative, tub > myc-expressing cells.
GFP clones in a NC environment (gray line). In p53 mutant discs, loser GFP+
s in (C)–(F) are SEM.
re allowed to grow for 24 hr.
loser clones (GFP+). Most C3-postive cells are GFP-negative (quantified in F).
in NC (Ctl) or per GFP+ clone in competitive tub > dmyc > Gal4 discs in WT or
arate channel in G0 ) marks cells with DNA damage. C3+ cells (red in G, single
most often in Myc supercompetitor cells (GFP-negative cells).
. Wing discs were heat shocked but lacked Flp, and thus no loser GFP+ clones
g-H2AX-positive cells in the disc epithelium. White arrows point to overlapping
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Figure 6. Myc Supercompetitor Status and
Survival Require p53
(A–C) MARCM experiments in which sibling clones
are p53 mutant. Error bars in this figure are SEM.
(A) Scheme showing progeny generated by FRT-
mediated (black squares) mitotic recombination.
The p53mutation segregates with Gal80 and CD2,
yielding p53 mutant sibling clones.
(B) Gal4, Myc clones compete against WT sibling
clones and grow larger than Gal4 control clones.
(C) WT Gal4, Myc clones compete against p53
mutant sibling clones.
(D–F)MARCM experiment in whichGal4 clones are
p53 mutant.
(D) Scheme showing progeny generated by mitotic
recombination. The p53mutation segregates away
from Gal80 and CD2, yielding p53 mutant Gal4
clones and WT sibling clones.
(E) WT clones, as in (B).
(F) p53 mutant Myc-expressing Gal4 clones are
significantly smaller than controls.
(G–I) Wing discs with MARCM clones of the indi-
cated genotype. P35 is expressed in Gal4 clones
(green) in (I). All sibling clones (magenta) are WT,
and blue cells are p53/+ (phenotypically WT).
(J) P35 expression in the Gal4 clones does not
affect competition between Gal4, Myc clones, and
WT sibling clones.
(K) Inhibition of cell death of p53 mutant, Gal4,
Myc clones allows them to grow equal to WT Gal4,
Myc clones, but they are not competitive.
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comes at the cost of life-threatening vulnerability to loss of
p53. Although the root cause of the vulnerability is unknown,
our results suggest several possibilities. In the absence of p53,
confrontation of Myc and WT cells leads to H2AX phosphoryla-
tion in Myc cells, thus DNA damagemay selectively compromise
survival of Myc supercompetitor cells. Myc cells have increased
reactive oxygen species (ROS;M.Z., unpublished data), possibly
arising from enhanced metabolic flux, which can cause genomic
damage (Greer et al., 2013; K et al., 2006). As p53 has antioxi-
dant functions (Budanov et al., 2004; Sablina et al., 2003), its
loss in Myc supercompetitors could intensify ROS and increase
genomic instability. In addition, confrontational stress coupled
with loss of p53’s ox-phos-promoting capacity could lead ATP480 Cell Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc.to fall below a critical threshold in the
Myc cells. However, when protected
from apoptosis, p53 mutant Myc super-
competitors proliferate with the same
kinetics and to the same extent as WT
Myc supercompetitors. Thus Myc re-
mains fully functional as a growth regu-
lator in p53 mutant cells and also still
stimulates glycolytic flux.
Regardless of the mechanism, the
phenotypic differences between Myc-
expressing cells and Myc-supercompeti-
tor cells provide a clear demonstration of
the determinative nature of cellular
context, a hallmark of cell competition.Given the conserved metabolic functions of Myc and p53 we
document here and the frequent activation of Myc family pro-
teins in cancer, our findings predict that homeostatic p53 activity
is induced to balance the glycolytic shift in incipient cancer cells.
Moreover, in normal tissues, confrontation with an emerging
patch of such precancerous cells could encourage tumor growth
and fitness by promoting the cells’ acquisition of supercompeti-
tor status. In this regard, the apparent cooperative relationship
between Myc and p53 in regulating supercompetition is parti-
cularly disquieting in terms of cancer. Two points are worth
considering further. First, cancer cells commonly take advantage
of glycolysis to fuel rapid energy production, but this is thought
to evolve over time in response to constraints on growth (such
as oxygen availability) as the tumor cells become invasive
Figure 7. A Model of Myc and p53-Dependent Reprogramming in
Cell Competition
(A) In a homotypic, NC milieu, high Myc activity increases glycolytic flux but
inhibits oxphos, reducing ATP levels. p53 is induced and promotes oxphos,
counteracting the effect of Myc and stabilizing ATP levels and thus fitness.
(B) In a heterotypic, C milieu of Myc-expressing and WT cells, confrontational
stress increases p53 activity, allowing Myc cells to acquire supercompetitor
status. As in (A), p53 promotes oxphos in response to glycolytic flux induced
by Myc expression. p53 also responds to confrontation with WT cells, further
increasing Myc cell fitness and characterized by enhanced glycolytic flux.
Supercompetitor status enables them to transmit a killing signal to their WT
neighbor cells, proliferate more, and expand their territory. Arrows in (A) and (B)
indicate direct or indirect relationships inferred from the data.
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Myc Supercompetition Requires p53(Gatenby andGillies, 2004). Myc-expressing cells acquire super-
competitor status within a few hours of confrontation with WT
cells (Senoo-Matsuda and Johnston, 2007), immediately giving
them a competitive advantage, suggesting that selective
pressure is not necessary for precancerous cells to acquire a
metabolic profile associated with supercompetitor behavior.
Second, although TP53 mutations are among the most frequent
in cancer, their tumor-promoting effects are only evident over
relatively long timescales, and additional mutations are impor-
tant for malignancy (Ziegler et al., 1994). We suggest that, like
Myc supercompetitor cells, precancerous cells arising among
otherwise healthy cells may initially require p53 for their survival.
Time and sensitivity to additional stresses could facilitate p53
loss, after which continued tumor growth would be predicted
to occur only in cells successful at adapting to its loss, an idea
supported by recent work in human cells (Maddocks et al.,
2013). Thus our finding that p53 is critically important for the
survival of supercompetitor cells could be relevant when con-
sidering therapies in early stages of tumor promotion.
EXPERIMENTAL PROCEDURES
Somatic Clones
The tub > myc > Gal4 cassette was used to generate random GFP-marked
tub > Gal4 clones (de la Cova et al., 2004). Tub > Gal4 clones were induced
by heat shock (HS) of larvae at 37C for 25 min at 48 hr after egg laying
(AEL), and animals were allowed to grow until the indicated time point. The
act > y, stop > Gal4 cassette was used to generate random GFP or Myc-
expressing act > Gal4 clones in WT wing discs. Act > Gal4 clones were
induced by larval HS at 37C for 15 min at 48 hr AEL and animals treated
as above. For p53 mutant clones we tested two null alleles, p53ns and
p535-a-1-4, which behaved similarly.
Clonal Growth Measurements
Clonal growth was determined by measuring the two-dimensional area of
clones (mm2). Clone size measurements were made using a Zeiss Axioplan 2Cemicroscope with an Orca-100 CCD camera (Hammatsu). Clone area was
measured at 2003 magnification using Axiovision 4.6 software.
Histology
Fixation, antibodies and staining of imaginal discs, and RNA in situ
hybridizations with digoxigenin-labeled RNA probes were done as described
(de la Cova et al., 2004). Images were acquired with Axiovision 4.6 or
Leica SP5 confocal system software. See the Supplemental Information for
details.
Cell Culture Assays
WT cells and Myc cells were plated for monoculture, direct coculture, or indi-
rect coculture at equal density and incubated 16 hr, after which medium was
replaced with medium ±125 mMCuSO4 (Senoo-Matsuda and Johnston, 2007).
Culture systems, C3 activity measurements, and growth assays were as in
Senoo-Matsuda and Johnston (2007).
ATP, Lactate, and Pyruvate Assays
WT cells and Myc cells were treated ced-9 (control) dsRNA or p53 dsRNA in
the absence of CuSO4 for 96 hr and then plated for monoculture or indirect
coculture for 16 hr (Senoo-Matsuda and Johnston, 2007). Cells were then
treated ±125 mM CuSO4 for 24 hr. For ATP analysis, the cells were lysed in
Reporter Lysis Buffer (Promega) and lysate used in the ATP Determination
Kit (Invitrogen). Lactate and Pyruvate Assay Kits (BioVision) were used as
per manufacturers’ instructions.
Glucose Consumption and 2-NBDG Assays
CM was collected from single, indirect, or direct cocultures of WT and Myc
cells and glucose assessed using the Glucose (GO) Assay Kit (Sigma). For
in vivo assessment of glucose uptake, wing imaginal discs were monitored
as follows: control RFP or RFP + Myc-expressing clones were induced at
48 hr AEL and larvae dissected at 96 hr AEL. Dissected larvae were incubated
in PBS with 0.25 mM 2-NBDG (Invitrogen) for 45 min at 25C, washed twice in
PBS for 10 min, fixed 20 min in PBS + 4% PFA, and washed again twice for
10 min in PBS. All washes and the fixation were done with precooled PBS
(4C). Imaginal discs were stained with Hoechst, rapidly dissected, and
mounted in Vectashield, and images were immediately collected with a Leica
SP5 confocal microscope. 2-NBDG fluorescence was excited at 488 nm
and detected at 500–520 nm. RFP fluorescence was excited at 543 nm and
emission detected at 550–645 nm (Zou et al., 2005).
Quantitative RT-PCR
WT or Myc cells were collected from monocultures or indirect cocultures
for analysis after 24 hr of the appropriate treatment. Reverse transcription
(RT) to produce single-stranded cDNA was performed using 0.5–1 mg total
RNA and SuperScript First-Strand Synthesis kit (Invitrogen). RT plus and
minus controls were done in parallel. Q-PCR reactions were performed using
LightCycler FastStart DNA MasterPlus SYBR Green I kit (Roche). Standard
curves were produced using serially diluted cDNA made from WT cells for
each primer set. Amplification was done using standard conditions in a Roche
LightCycler. act5C mRNA was used to normalize data. Primer sequences
are listed in Table S1.
dsRNA Treatment
WT or Myc cells were pretreated with dsRNA against ced-9 or gfp (used
as controls), p53, glut1, cyt-c-d, or debcl for 72–96 hr as described (Senoo-
Matsuda and Johnston, 2007). See the Supplemental Information for details.
Mitochondrial Respiratory Chain Complex Activities
Complex activities were measured according to DiMauro et al. (1987). See the
Supplemental Information for details.
Statistics
All values are means of R3 independent experiments. Student’s t test was
used to determine significance (two-tailed, unequal variance). p values are
as follows: * p < 0.05,** p < 0.01, *** p < 0.001. All error bars are standard
deviation (SD) unless otherwise indicated in the figure legend.ll Metabolism 19, 470–483, March 4, 2014 ª2014 Elsevier Inc. 481
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